Initial trials of the potential vaccine could begin in April, but the process of testing and approvals would last at least a year.
The Wall Street Journal, which was first to report the development, said that two doses of the vaccine would be tested on up to 25 volunteers to see if it produces an immune response that protects against the virus. Fauci previously told CNN that researchers could expedite the approval process for a vaccine following a successful Phase 1 trial in an attempt to halt the spread of the virus.
While the experimental vaccine developed by Moderna remains unproven, the speed at which it was created represents a breakthrough.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: